Genesis Prize 2022

• 20 Jan 2022

• Albert Bourla, chairman and CEO of Pfizer, has been awarded the 2022 Genesis Prize for his “leadership, determination and especially for his willingness to assume great risks” in developing a coronavirus vaccine in record time.
• Pfizer's vaccine was the first to win U.S. approval for emergency use in December 2020.
• The Genesis Prize is a $1 million annual prize awarded to Jewish people who have achieved significant professional success, in recognition of their accomplishments, contributions to humanity, and commitment to Jewish values.
• The prize was inaugurated in 2014 and is run in a partnership between the private Genesis Prize Foundation and the chairman’s office of the Jewish Agency, a nonprofit group that has close ties to the Israeli government.
• The prize is usually awarded in Jerusalem each June at a dinner attended by Israel’s prime minister. But the ceremony has been called off the past two years due to the pandemic.